Overview
Janashakthi Insurance is a Sri Lankan life and health insurer, supported by policy renewals, new business distribution, micro-insurance and an investment portfolio. The central tension is clear: reported premium momentum has strengthened, but the latest filed earnings have not kept pace.
Price performance
The share closed at LKR 43.50 on 14 August 2026. On a split-adjusted basis, it gained 74.7% over one year but fell 8.4% over three months, compared with ASPI returns of 9.3% and negative 5.6% over the same periods. The six-month return was 0.2%, against negative 9.2% for the ASPI.
The April 2026 1:3 subdivision changed the traded share basis, so adjusted returns are the appropriate performance measure. The price sat at 63.1% of its 52-week range, 20.8% below the high. Recent volatility was 28.2%, 39.2% below its own one-year level, while 20-day volume was 15.5% below the 60-day average.
Valuation
Janashakthi trades at a P/E of 9.12, placing it at the 11th sector percentile, while its P/B of 1.76 sits at the 60th percentile among insurance peers. The valuation is therefore inexpensive on earnings but closer to the sector middle on book value. Its 2025 audited ROE was 20.8%, which provides support for a book-value multiple above the cheapest insurers.
The 7.7% dividend yield is backed by a payout that has risen across the recorded history: dividend per share was LKR 0.883 in FY2022, LKR 4.41 in FY2023 and LKR 5.00 in FY2025. FY2024 has no dividend recorded in the supplied history, so the latest yield should not be treated as a continuously rising annual series.
News and sentiment
Company coverage was about normal, with one article in the last 30 days against a baseline of 1.3, and the 90-day material split was one positive article with no negative or neutral items. The latest report, dated 14 August 2026, cited H1 gross written premiums of LKR 5.11 billion, profit before tax of LKR 271 million and total assets of LKR 41.14 billion.
The confirmed 1:3 share subdivision became effective on 9 April 2026. Two independent non-executive directors were appointed effective 20 April 2026, subject to regulatory notification.
Financials
For the quarter ended 30 June 2026, group revenue fell 8.1% year-on-year to LKR 3.03 billion and net profit fell 98.5% to LKR 16 million. Net margin dropped from 31.2% to 0.5%; the latest result ranked fifth of six comparable June quarters, making it one of the company’s weakest like-for-like outcomes. Gross and operating margins were not reported for either comparable quarter.
Owners’ equity was LKR 16.77 billion at June 2026. The April subdivision lifted the reported share count to 679.578 million, so earlier per-share figures must be adjusted before comparison. The latest filed quarter is now historical relative to the 14 August H1 update: that newer report showed 36% growth in gross written premiums, but it did not provide a comparable net-profit figure.
Risks
The main risk is earnings volatility: the latest group quarter produced only a 0.5% net margin and ranked fifth of six comparable June quarters, despite stronger reported premium growth in H1. This makes the earnings base difficult to assess from the latest filing alone.
At 31 December 2025, total debt was LKR 1.46 billion and gearing was 10.4% of owners’ equity. Interest cover, the current ratio and cash conversion are not reported in the supplied balance-sheet data and are not standard measures for an insurer. Falling Treasury yields, with three- to 12-month bill rates reported at 9.44% to 10.01%, also matter because insurers invest policyholder funds in fixed income and lower yields can affect portfolio returns.
Outlook
As at 15 August 2026, the next scheduled filing covers the quarter ending 30 September 2026 and is expected between 7 November 2026 and 7 January 2027. That filing is the next clear test of whether the weak June earnings print was temporary or part of a broader deterioration; the supplied H1 news already confirms that premium growth remained strong.
The data does not yet show how the reported 36% H1 gross written premium growth translated into net profit or investment income. The next filing should therefore be read alongside the company’s asset mix and earnings below the premium line, while lower sector bond yields remain an external pressure on insurers’ investment returns.